<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04622540</url>
  </required_header>
  <id_info>
    <org_study_id>SNUHLT_EBD</org_study_id>
    <nct_id>NCT04622540</nct_id>
  </id_info>
  <brief_title>EBD RCT Trial in Living Donor Liver Transplantation</brief_title>
  <official_title>A Prospective Randomized Controlled Trial for Application of External Biliary Drainage in Living Donor Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed to demonstrate incidence of biliary complication rates after living&#xD;
      donor liver transplantation according to the implantation of external biliary drainage throug&#xD;
      duct-to-duct anastomosis site.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Biliary complication is the most common complications after liver transplantation, and it&#xD;
      happens more often after living donor liver transplantation (LDLT) than deceased donor liver&#xD;
      transplantation.&#xD;
&#xD;
      Many transplant centers adopted their own methods to improve biliary complications after&#xD;
      LDLT. One suggested method is the application of external biliary drainage (EBD).&#xD;
&#xD;
      A prospective study was planned to demonstrate effect of EBD on biliary complication after&#xD;
      LDLT. Patients who underwent LDLT with duct-to-duct anastomosis will be randomly assinged to&#xD;
      application of EBD or conventional duct-to-duct anastomosis without EBD according to a&#xD;
      computer generated randomization sequence and allocated in a 1:1 ratio to one of two groups.&#xD;
&#xD;
      Primary outcome is biliary complication incidence 1 year after LDLT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 9, 2020</start_date>
  <completion_date type="Anticipated">November 2026</completion_date>
  <primary_completion_date type="Anticipated">November 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of biliary complication within 1 year after LDLT</measure>
    <time_frame>1 year</time_frame>
    <description>Biliary stricture/leakage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of biliary complication within 3 year after LDLT</measure>
    <time_frame>3 year</time_frame>
    <description>Biliary stricture/leakage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication associated with external biliary drainage</measure>
    <time_frame>3 year</time_frame>
    <description>Dislocation, retraction, reposition, leakage through tube site, hemorrhage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Graft survival</measure>
    <time_frame>3 year</time_frame>
    <description>Survival of liver graft</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient survival</measure>
    <time_frame>3 year</time_frame>
    <description>Patient survival after LDLT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported outcome</measure>
    <time_frame>3 year</time_frame>
    <description>Questionnaire survey</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Liver Transplantation</condition>
  <condition>Liver Transplant; Complications</condition>
  <condition>Bile Stricture</condition>
  <condition>Bile Leakage From Biliary Anastomosis</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of external biliary drainage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conventional duct-to-duct anastomosis (with or without internal stent)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>External biliary drainage</intervention_name>
    <description>Application of external biliary drainage through duct-to-duct anastomosis</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Living donor liver transplantation&#xD;
&#xD;
          -  Adult patient (&gt;=18 years old)&#xD;
&#xD;
          -  Patients who are available for at least 3 year follow-up after LDLT&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients requring hepaticojejunostomy due to anatomical factor or underlying disease&#xD;
&#xD;
          -  Re-transplantation&#xD;
&#xD;
          -  Multiorgan transplantation&#xD;
&#xD;
          -  Emergency transplantation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suk Kyun Hong, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Su young Hong, MD</last_name>
    <phone>+82-2-2072-2326</phone>
    <email>sypurple@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suk Kyun Hong</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, Fair JH, Fisher RA, Olthoff KM, Trotter JF, Ghobrial RM, Everhart JE; A2ALL Study Group. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant. 2008 Dec;8(12):2569-79. doi: 10.1111/j.1600-6143.2008.02440.x. Epub 2008 Oct 24.</citation>
    <PMID>18976306</PMID>
  </reference>
  <reference>
    <citation>Akamatsu N, Sugawara Y, Hashimoto D. Biliary reconstruction, its complications and management of biliary complications after adult liver transplantation: a systematic review of the incidence, risk factors and outcome. Transpl Int. 2011 Apr;24(4):379-92. doi: 10.1111/j.1432-2277.2010.01202.x. Epub 2010 Dec 10. Review.</citation>
    <PMID>21143651</PMID>
  </reference>
  <reference>
    <citation>Hwang S, Lee SG, Sung KB, Park KM, Kim KH, Ahn CS, Lee YJ, Lee SK, Hwang GS, Moon DB, Ha TY, Kim DS, Jung JP, Song GW. Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation. Liver Transpl. 2006 May;12(5):831-8.</citation>
    <PMID>16528711</PMID>
  </reference>
  <reference>
    <citation>Jung DH, Ikegami T, Balci D, Bhangui P. Biliary reconstruction and complications in living donor liver transplantation. Int J Surg. 2020 Oct;82S:138-144. doi: 10.1016/j.ijsu.2020.04.069. Epub 2020 May 5. Review.</citation>
    <PMID>32387205</PMID>
  </reference>
  <reference>
    <citation>Park CS, Jung BH, Hwang S, Park YH, Kang SH, Park GC, Song GW, Jung DH, Ahn CS, Kim KH, Moon DB, Ha TY, Lee SG. External biliary drainage in living donor liver transplantation using duct-to-duct anastomosis. Transplant Proc. 2014 Apr;46(3):678-81. doi: 10.1016/j.transproceed.2013.11.150.</citation>
    <PMID>24767322</PMID>
  </reference>
  <reference>
    <citation>Lee SG. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant. 2015 Jan;15(1):17-38. doi: 10.1111/ajt.12907. Epub 2014 Oct 30. Review.</citation>
    <PMID>25358749</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 4, 2020</study_first_submitted>
  <study_first_submitted_qc>November 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2020</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Suk Kyun Hong</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

